All Type of News
Novartis scientist visit to Korea for a cancer scientific seminar.
Dr. D. Young, the vice president responsible for the Novartis global clinical research on phase II/III studies, visited to Korea for the Asia-Pacific Scientific Seminar on Cancer in Seoul, staying 4 days.
Dr. Young...
HIRA to hold symposium for evidence based medicine
The Health Insurance Review Agency (HIRA) announced an international symposium titled "the present and future of the evidence based medicine in the healthcare medical system" at Lotte hotel on Sept. 13 (Tuesday).
T...
Novartis Korea to finish a successful promotional campaign.Following a successful event of "Power Summit of Cardiovascular Internal Medical Doctors" working at general hospitals, Novartis Korea has satisfactorily achieved another campai...
|
Hanmi received KT mark on Amodipin.Hanmi recently received the domestic technology award of "Excellent Korean Technology" for Amodipin, an anti-hypertension drug during the Q3 2005 Technology Recognition occasion...
|
Korea and Italy joint symposium on infective diseases.
The Korea Center for Disease Control and Prevention (KCDC) and the National Institute of Health (NIH) planned a joint symposium with Italian embassy in Korea over "The present and future of the infective disease studi...
Massive administrative penalty against 2000 pharmacies.
More than 2,000 pharmacies have faced a massive administrative punishment on charge of dispensing PPA up to May this year since it was banned to sell any cold remedies containing PPA (phenylpropanolamine).
It wa...
Hanyak Maul to construct GMP plant for hyaluronic acid production.Hanyak Maul Inc. is a venture company founded by the college students and professors of Kyunghee Univ. College of Herbal Pharmacy at 200 million won of the capital supported by ...
|
KPTA wanted companies to participate in 54th PharmChina exhibition.
The Korea Pharmaceutical Trade Association (KPTA) invited the candidates until Sept. 20 who wish to participate in the 54th PharmChina exhibition at Chongqing International Convention & Exhibition Center from Dec. 1 t...
Zuellig's labor union strike closed on the dawn of Sept. 9.
The Zuellig management and its labor union have reached an agreement for 9% of wage raise including 8% of basic plus 1% of career allowance and fixed money payment at 1.2 million won along with new 5 regular employees...
Total 39 new drugs under DMF controls.
The KFDA announced to include the total 39 new ingredients including "imatinib mesylate" a drug for leukemia (Glivec) and other 4 new drugs registered in Korea since July 2002 to the drug master file (DMF) system.
...
